These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 20005600)
1. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD. George S; Mufson EJ; Leurgans S; Shah RC; Ferrari C; deToledo-Morrell L Neurobiol Aging; 2011 Oct; 32(10):1756-64. PubMed ID: 20005600 [TBL] [Abstract][Full Text] [Related]
2. Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease. Shen Q; Loewenstein DA; Potter E; Zhao W; Appel J; Greig MT; Raj A; Acevedo A; Schofield E; Barker W; Wu Y; Potter H; Duara R Alzheimers Dement; 2011 Jul; 7(4):e101-8. PubMed ID: 21784342 [TBL] [Abstract][Full Text] [Related]
3. Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region. Muth K; Schönmeyer R; Matura S; Haenschel C; Schröder J; Pantel J Biol Psychiatry; 2010 Mar; 67(6):588-91. PubMed ID: 19375072 [TBL] [Abstract][Full Text] [Related]
4. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. Mah L; Binns MA; Steffens DC; Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120 [TBL] [Abstract][Full Text] [Related]
5. Volumetric brain changes in thalamus, corpus callosum and medial temporal structures: mild Alzheimer's disease compared with amnestic mild cognitive impairment. Pedro T; Weiler M; Yasuda CL; D'Abreu A; Damasceno BP; Cendes F; Balthazar ML Dement Geriatr Cogn Disord; 2012; 34(3-4):149-55. PubMed ID: 22986782 [TBL] [Abstract][Full Text] [Related]
6. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654 [TBL] [Abstract][Full Text] [Related]
7. Structural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM study. Colloby SJ; Elder GJ; Rabee R; O'Brien JT; Taylor JP Int J Geriatr Psychiatry; 2017 Jun; 32(6):615-623. PubMed ID: 27197956 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the substantia innominata volume in patients with Parkinson's disease with dementia, dementia with lewy bodies, and Alzheimer's disease. Kim HJ; Lee JE; Shin SJ; Sohn YH; Lee PH J Mov Disord; 2011 Oct; 4(2):68-72. PubMed ID: 24868398 [TBL] [Abstract][Full Text] [Related]
13. Reduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease. Jaswal G; Swardfager W; Gao FQ; Nestor SM; Ganda A; Cogo-Moreira H; Sahlas DJ; Stuss DT; Moody A; Black SE Neurobiol Aging; 2018 Jun; 66():23-31. PubMed ID: 29505952 [TBL] [Abstract][Full Text] [Related]
14. Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects? Moon WJ; Kim HJ; Roh HG; Han SH AJNR Am J Neuroradiol; 2008 Aug; 29(7):1308-13. PubMed ID: 18436612 [TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease. Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory. Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659 [TBL] [Abstract][Full Text] [Related]
17. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia. Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476 [TBL] [Abstract][Full Text] [Related]
18. Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease? Gao FQ; Pettersen JA; Bocti C; Nestor SM; Kiss A; Black SE Neurobiol Aging; 2013 Jul; 34(7):1807-14. PubMed ID: 23414670 [TBL] [Abstract][Full Text] [Related]
19. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment. Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807 [TBL] [Abstract][Full Text] [Related]
20. A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease. Barnes DE; Cenzer IS; Yaffe K; Ritchie CS; Lee SJ; Alzheimers Dement; 2014 Nov; 10(6):646-55. PubMed ID: 24495339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]